In other words, says Ms Rowe, “there are considerable risks associated with SARS-CoV-2 infection” beyond the initial COVID-19 illness.
“You are 15 times more likely to acquire myocarditis requiring hospitalizations following COVID-19 compared with beforehand,” she said.
“Things like heart attacks, or acute myocardial infarction occur quite proximally to getting COVID infection, but other conditions such as the clotting conditions – pulmonary embolism, for example — that risk was highest later in the course of COVID illness, highest around 14 to 60 days following COVID illness.”.
“Our findings indicate the need for ongoing COVID-19 mitigation measures, including vaccination, and support the early diagnosis and management of complications in people with histories of SARS-CoV-2 infection,” they wrote.
“Some COVID-19 complications clinically resemble those reported after vaccination against SARS-CoV-2, which is important when evaluating putatively post-vaccination adverse events
“What we found with this study, and what other studies have found internationally is the risk of myocarditis is higher following SARS-CoV-2 infection, than it is following vaccination
COVID itself can cause myocarditis at a higher rate [than vaccination]